Temporal Lobe Gliosarcoma after Gamma Knife Radiosurgery for Vestibular Schwannoma

Joseph R. Kapurch, Jeffrey T. Jacob, Matthew L. Carlson, John L. Atkinson, Aditya Raghunathan, Michael J. Link

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: Secondary tumorigenesis after exposure to ionizing radiation is a well-described phenomenon. The probability of developing a malignancy after stereotactic radiosurgery (SRS) is theoretically less than conventional external beam radiation therapy; however, the exact risk remains unknown. Such information is important for patient counseling when considering treatment of benign conditions such as vestibular schwannoma (VS). The objective of the current report is to describe a case of a temporal lobe gliosarcoma developing 3 years after radiosurgical treatment of a sporadic VS. Setting: Tertiary academic referral center. Patient: A 54-year-old man was diagnosed with a left-sided 1.6 cm cerebellopontine angle mass, consistent with VS. After reviewing treatment options, the patient proceeded with radiosurgery, and a tumor volume of 2.4 cm 3 was treated with a marginal dose of 12.5 Gy prescribed to the 50% isodose line. Results: Serial magnetic resonance imaging (MRI) revealed good treatment response, demonstrated by central necrosis and tumor shrinkage. However, 3 years after treatment, the patient presented to the emergency department for a month long history of progressive word finding difficulties. Imaging revealed a 5 cm temporal lobe mass consistent with a high-grade glial neoplasm. He subsequently underwent stereotactic resection and final pathology confirmed World Health Organization Grade IV gliosarcoma. Conclusion: De novo malignancy after radiosurgery for VS is rare. We present only the second case of a gliosarcoma arising within the low-dose radiation field of the radiosurgery treatment plan. Some of the challenges of establishing causality between radiation treatment and secondary tumor development are discussed. The reporting of malignancy after radiation therapy, and even microsurgery, warrants continued vigilance.

Original languageEnglish (US)
Pages (from-to)1143-1147
Number of pages5
JournalOtology and Neurotology
Volume37
Issue number8
DOIs
StatePublished - Sep 1 2016

Fingerprint

Gliosarcoma
Acoustic Neuroma
Radiosurgery
Temporal Lobe
Neoplasms
Therapeutics
Radiotherapy
Radiation
Cerebellopontine Angle
Microsurgery
Ionizing Radiation
Tumor Burden
Tertiary Care Centers
Neuroglia
Causality
Hospital Emergency Service
Counseling
Carcinogenesis
Necrosis
Magnetic Resonance Imaging

Keywords

  • Acoustic neuroma
  • Gamma Knife
  • Radiation-induced malignancy
  • Radiosurgery
  • Vestibular schwannoma

ASJC Scopus subject areas

  • Medicine(all)
  • Otorhinolaryngology
  • Sensory Systems
  • Clinical Neurology

Cite this

Temporal Lobe Gliosarcoma after Gamma Knife Radiosurgery for Vestibular Schwannoma. / Kapurch, Joseph R.; Jacob, Jeffrey T.; Carlson, Matthew L.; Atkinson, John L.; Raghunathan, Aditya; Link, Michael J.

In: Otology and Neurotology, Vol. 37, No. 8, 01.09.2016, p. 1143-1147.

Research output: Contribution to journalArticle

Kapurch, Joseph R. ; Jacob, Jeffrey T. ; Carlson, Matthew L. ; Atkinson, John L. ; Raghunathan, Aditya ; Link, Michael J. / Temporal Lobe Gliosarcoma after Gamma Knife Radiosurgery for Vestibular Schwannoma. In: Otology and Neurotology. 2016 ; Vol. 37, No. 8. pp. 1143-1147.
@article{6486a72b2e504bd5afbeef599cf9d684,
title = "Temporal Lobe Gliosarcoma after Gamma Knife Radiosurgery for Vestibular Schwannoma",
abstract = "Objective: Secondary tumorigenesis after exposure to ionizing radiation is a well-described phenomenon. The probability of developing a malignancy after stereotactic radiosurgery (SRS) is theoretically less than conventional external beam radiation therapy; however, the exact risk remains unknown. Such information is important for patient counseling when considering treatment of benign conditions such as vestibular schwannoma (VS). The objective of the current report is to describe a case of a temporal lobe gliosarcoma developing 3 years after radiosurgical treatment of a sporadic VS. Setting: Tertiary academic referral center. Patient: A 54-year-old man was diagnosed with a left-sided 1.6 cm cerebellopontine angle mass, consistent with VS. After reviewing treatment options, the patient proceeded with radiosurgery, and a tumor volume of 2.4 cm 3 was treated with a marginal dose of 12.5 Gy prescribed to the 50{\%} isodose line. Results: Serial magnetic resonance imaging (MRI) revealed good treatment response, demonstrated by central necrosis and tumor shrinkage. However, 3 years after treatment, the patient presented to the emergency department for a month long history of progressive word finding difficulties. Imaging revealed a 5 cm temporal lobe mass consistent with a high-grade glial neoplasm. He subsequently underwent stereotactic resection and final pathology confirmed World Health Organization Grade IV gliosarcoma. Conclusion: De novo malignancy after radiosurgery for VS is rare. We present only the second case of a gliosarcoma arising within the low-dose radiation field of the radiosurgery treatment plan. Some of the challenges of establishing causality between radiation treatment and secondary tumor development are discussed. The reporting of malignancy after radiation therapy, and even microsurgery, warrants continued vigilance.",
keywords = "Acoustic neuroma, Gamma Knife, Radiation-induced malignancy, Radiosurgery, Vestibular schwannoma",
author = "Kapurch, {Joseph R.} and Jacob, {Jeffrey T.} and Carlson, {Matthew L.} and Atkinson, {John L.} and Aditya Raghunathan and Link, {Michael J.}",
year = "2016",
month = "9",
day = "1",
doi = "10.1097/MAO.0000000000001112",
language = "English (US)",
volume = "37",
pages = "1143--1147",
journal = "Otology and Neurotology",
issn = "1531-7129",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Temporal Lobe Gliosarcoma after Gamma Knife Radiosurgery for Vestibular Schwannoma

AU - Kapurch, Joseph R.

AU - Jacob, Jeffrey T.

AU - Carlson, Matthew L.

AU - Atkinson, John L.

AU - Raghunathan, Aditya

AU - Link, Michael J.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Objective: Secondary tumorigenesis after exposure to ionizing radiation is a well-described phenomenon. The probability of developing a malignancy after stereotactic radiosurgery (SRS) is theoretically less than conventional external beam radiation therapy; however, the exact risk remains unknown. Such information is important for patient counseling when considering treatment of benign conditions such as vestibular schwannoma (VS). The objective of the current report is to describe a case of a temporal lobe gliosarcoma developing 3 years after radiosurgical treatment of a sporadic VS. Setting: Tertiary academic referral center. Patient: A 54-year-old man was diagnosed with a left-sided 1.6 cm cerebellopontine angle mass, consistent with VS. After reviewing treatment options, the patient proceeded with radiosurgery, and a tumor volume of 2.4 cm 3 was treated with a marginal dose of 12.5 Gy prescribed to the 50% isodose line. Results: Serial magnetic resonance imaging (MRI) revealed good treatment response, demonstrated by central necrosis and tumor shrinkage. However, 3 years after treatment, the patient presented to the emergency department for a month long history of progressive word finding difficulties. Imaging revealed a 5 cm temporal lobe mass consistent with a high-grade glial neoplasm. He subsequently underwent stereotactic resection and final pathology confirmed World Health Organization Grade IV gliosarcoma. Conclusion: De novo malignancy after radiosurgery for VS is rare. We present only the second case of a gliosarcoma arising within the low-dose radiation field of the radiosurgery treatment plan. Some of the challenges of establishing causality between radiation treatment and secondary tumor development are discussed. The reporting of malignancy after radiation therapy, and even microsurgery, warrants continued vigilance.

AB - Objective: Secondary tumorigenesis after exposure to ionizing radiation is a well-described phenomenon. The probability of developing a malignancy after stereotactic radiosurgery (SRS) is theoretically less than conventional external beam radiation therapy; however, the exact risk remains unknown. Such information is important for patient counseling when considering treatment of benign conditions such as vestibular schwannoma (VS). The objective of the current report is to describe a case of a temporal lobe gliosarcoma developing 3 years after radiosurgical treatment of a sporadic VS. Setting: Tertiary academic referral center. Patient: A 54-year-old man was diagnosed with a left-sided 1.6 cm cerebellopontine angle mass, consistent with VS. After reviewing treatment options, the patient proceeded with radiosurgery, and a tumor volume of 2.4 cm 3 was treated with a marginal dose of 12.5 Gy prescribed to the 50% isodose line. Results: Serial magnetic resonance imaging (MRI) revealed good treatment response, demonstrated by central necrosis and tumor shrinkage. However, 3 years after treatment, the patient presented to the emergency department for a month long history of progressive word finding difficulties. Imaging revealed a 5 cm temporal lobe mass consistent with a high-grade glial neoplasm. He subsequently underwent stereotactic resection and final pathology confirmed World Health Organization Grade IV gliosarcoma. Conclusion: De novo malignancy after radiosurgery for VS is rare. We present only the second case of a gliosarcoma arising within the low-dose radiation field of the radiosurgery treatment plan. Some of the challenges of establishing causality between radiation treatment and secondary tumor development are discussed. The reporting of malignancy after radiation therapy, and even microsurgery, warrants continued vigilance.

KW - Acoustic neuroma

KW - Gamma Knife

KW - Radiation-induced malignancy

KW - Radiosurgery

KW - Vestibular schwannoma

UR - http://www.scopus.com/inward/record.url?scp=84975106320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975106320&partnerID=8YFLogxK

U2 - 10.1097/MAO.0000000000001112

DO - 10.1097/MAO.0000000000001112

M3 - Article

C2 - 27309712

AN - SCOPUS:84975106320

VL - 37

SP - 1143

EP - 1147

JO - Otology and Neurotology

JF - Otology and Neurotology

SN - 1531-7129

IS - 8

ER -